Cumberland Pharmaceuticals Inc. CPIX

Company Overview

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of prescription products primarily for hospital acute care, gastroenterology, and oncology-supportive care markets. The company operates within the biopharmaceutical and specialty therapeutics industries and derives revenue mainly from branded pharmaceutical product sales, licensing arrangements, and royalty streams. Its portfolio includes products such as Acetadote for acetaminophen overdose, Caldolor for injectable ibuprofen pain management, Kristalose for chronic constipation, Vibativ for antibacterial treatment, and Sancuso for chemotherapy-induced nausea and vomiting.

The company was founded in 1999 by A.J. Kazimi and is headquartered in Nashville, Tennessee. Cumberland evolved from a hospital-focused specialty pharmaceutical business into a diversified branded therapeutics company through product acquisitions, in-licensing agreements, and internal clinical development efforts. The company’s strategy has historically emphasized acquiring under-promoted approved drugs and expanding their commercial reach through targeted sales infrastructure and lifecycle management initiatives. Its positioning centers on niche prescription products serving specialized physician and institutional markets with relatively limited direct competition.